About PBS Biotech
PBS Biotech is a company based in Camarillo (United States) founded in 2006. PBS Biotech has raised $70.21 million across 4 funding rounds from investors including Broadoak Capital Partners and Avego. PBS Biotech offers products and services including PBS-0.1 Mini Bioreactors, PBS-0.5 Mini Bioreactors, PBS-3 Bioreactors, PBS-15 Bioreactors, and PBS-80 Bioreactors. PBS Biotech operates in a competitive market with competitors including Limula, m2p-labs, Membio, Bionet Engineering and MicroBiopharm Japan, among others.
- Headquarter Camarillo, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pbs Biotech, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$70.21 M (USD)
in 4 rounds
-
Latest Funding Round
$17 M (USD), Series B
Jan 06, 2025
-
Investors
Broadoak Capital Partners
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PBS Biotech
PBS Biotech offers a comprehensive portfolio of products and services, including PBS-0.1 Mini Bioreactors, PBS-0.5 Mini Bioreactors, PBS-3 Bioreactors, PBS-15 Bioreactors, and PBS-80 Bioreactors.
Small-scale single-use bioreactor for cell culture in therapy development
Mini bioreactor for scaling cell therapy processes and yields
Mid-scale bioreactor for advanced cell and gene therapy applications
Larger bioreactor for production-scale cell therapy manufacturing
High-capacity bioreactor for extensive cell therapy development
People of PBS Biotech
Unlock access to complete
Software Development Team
13 people
Advisor Team
12 people
Senior Team
5 people
Sales and Marketing
5 people
Service Team
2 people
Finance and Accounting
2 people
Leadership Team
2 people
Applications Team
2 people
Unlock access to complete
Funding Insights of PBS Biotech
PBS Biotech has successfully raised a total of $70.21M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $17 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PBS Biotech
PBS Biotech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Broadoak Capital Partners and Avego.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward the healthcare sector.
|
Locked | Locked | Locked | |
|
Investment banking services are offered in the United States.
|
Locked | Locked | Locked |
Investor details for PBS Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PBS Biotech
Investment portfolio details for PBS Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PBS Biotech
Detailed financials for PBS Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pbs Biotech Comparisons
Peer comparison for PBS Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PBS Biotech
PBS Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Limula, m2p-labs, Membio, Bionet Engineering and MicroBiopharm Japan, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Modular solutions for on-demand cell therapy manufacturing are provided.
|
|
| Locked | Locked | Locked |
Micro-bioreactors are provided for screening and bioprocess development.
|
|
| Locked | Locked | Locked |
Developer of single-use bioreactors for cell and gene therapies
|
|
| Locked | Locked | Locked |
Manufactures bioreactors, TFF systems, and software for biopharma and agri-food applications.
|
|
| Locked | Locked | Locked |
Contract research and discovery services are provided to biopharma firms.
|
Detailed competitors of PBS Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pbs Biotech
Complete news archive for PBS Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PBS Biotech
PBS Biotech was founded in 2006 and raised its 1st funding round 15 years after it was founded.
PBS Biotech is headquartered in Camarillo, United States. It is registered at Camarillo, California, United States.
PBS Biotech is a funded company, having raised a total of $70.21M across 4 funding rounds to date.
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies. Their products include PBS MINI for early-stage process development, PBS 3 for laboratory RD applications, PBS 15 for laboratory RD and pre-clinical applications, PBS 80 for laboratory RD applications to clinical pilot production applications, PBS 500 for clinical and commercial production applications.
PBS Biotech offers PBS-0.1 Mini Bioreactors, PBS-0.5 Mini Bioreactors, PBS-3 Bioreactors, PBS-15 Bioreactors, and PBS-80 Bioreactors.
PBS Biotech has 2 investors. Key investors include Broadoak Capital Partners, and Avego.